Welcome to

Medicines Advice Initiative Australia

Supporting Quality Use of Medicines

Learn More

Current Topic

Recovery from depression

June 2025

MAIA-Recovering-From-Despression_Patient-with-Doctor@0.33x

Empowering recovery from depression: new evidence for GPs

Research highlights the protective role of lifestyle interventions in preventing relapse and possibly reducing the risk of depression. There is also improved understanding of withdrawal symptoms associated with stopping antidepressants. Together, this evidence guides GPs in using antidepressants as part of a recovery-focused approach, with the aim of eventual withdrawal.

Recent Topics

Cumulative Medicines (re-release)

May 2025

Medicines can provide many benefits to treat and prevent health problems, but they come with risks. Medicines that were once helpful when first prescribed, may no longer be helpful or become unsafe. By assessing cumulative medicine risk, utilising Medicines Reviews and initiating deprescribing, GPs can take action to reduce medicine related harm and improve the health outcomes of their patients.

Read More

Heart Failure

February 2025

Heart failure is estimated to affect around 318,000 Australians, with over 60,000 diagnosed every year. The use of recommended medicines is a key factor in reducing hospital admissions and improving survival in people with heart failure with reduced ejection fraction (HFrEF).

Read More

Diabetes Medicines

November 2024

Diabetes is the fastest growing chronic condition in Australia, increasing at a faster rate than other chronic diseases such as heart disease and cancer. It is important to regularly assess the absolute cardiovascular risk and risk of chronic kidney disease (CKD) for all your patients with T2DM.

Read More
About MAIA

Medicines Advice Initiative Australia (MAIA) is a consortium dedicated to improving the use of medicines and related health services in Australia.

READ MORE
MAIA-Logo-Full-colour